Apr-15 – Ataxia

Apr-15

Apr-15

Horizon Pharma plc receives FDA fast track designation for ACTIMMUNE® in the treatment of friedreich’s ataxia

A new drug, ACTIMMUNE® (interferon gamma-1b) has been designated fast track status by the U.S Food and Drug Administration, which could make it available sooner.

Posted: 10/04/2015

The international ataxia research conference 2015 hailed a great success!

The IARC 2015 covered a range of research areas from new developments in genetics to clinical trials, with representatives from several pharmaceutical agencies and researchers from all four corners of the world in attendance.

Posted: 03/04/2015

SUBSCRIBE TO OUR NEWSLETTER

Something went wrong. Please check your entries and try again.
fundraise image

FUNDRAISE FOR US

Take part in a challenge or create your fundraiser. Every penny you raise will help those affected by ataxia.

Donate Image

DONATE

To make either a one off or recurring donation which will help fund research into treatments and cures and supports those affected ataxia

Volunteer Image

VOLUNTEER WITH US

Support the ataxia community and volunteer with Ataxia UK. From social media to telephone befriending, there are loads of ways you can make a difference to someone's life.

Donate Now
Welcome to our new site! We hope you like it.
As it's brand new, there may be a few temporary glitches such as broken links - we are working on getting these all fixed ASAP. If you'd like to give us any feedback or let us know if something isn't quite right, please email website@ataxia.org.uk
+
Scroll to Top